[{"uuid": "52aae86c-4d7c-35d7-81b3-876ca20bab1c", "title": "CRL Gears Up for Q4 Earnings: Here's What You Need to Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/crl-gears-q4-earnings-heres-124400066.html", "providerPublishTime": 1738586640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XZlfIZsWv4Zk8B16YMQW3g--~B/aD0zNjA7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9137c6f6ed305652874fd6a3a724cf37", "width": 620, "height": 360, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/basziZN2oibsd7YoTsUvFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9137c6f6ed305652874fd6a3a724cf37", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRL"]}, {"uuid": "e4d63105-94d7-39ab-93ef-14c0503b3e11", "title": "STE Gears Up for Q3 Earnings: Here's What You Need to Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/ste-gears-q3-earnings-heres-142000266.html", "providerPublishTime": 1738333200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_aMgtCHWD_AcEvdCSVRbpA--~B/aD00NDU7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62a1df11c94046acffed2654620317fb", "width": 620, "height": 445, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFfQIuDEO9advS2K1dktJw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/62a1df11c94046acffed2654620317fb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["STE"]}, {"uuid": "b4e082ce-faad-38cb-8996-163410748cbb", "title": "ALGN Gears Up for Q4 Earnings: What Lies Ahead for the Stock?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/algn-gears-q4-earnings-lies-133600369.html", "providerPublishTime": 1738157760, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/hbnriVQO_YULm.6Alary2A--~B/aD00NzM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/284f918f27be0f0da586713eec133185", "width": 620, "height": 473, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/VgB380OJhAunKKDx_dL_2Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/284f918f27be0f0da586713eec133185", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGN"]}, {"uuid": "b65b6f04-92d5-376f-a21e-e57e7db3dc35", "title": "Are Medical Stocks Lagging  Addus HomeCare (ADUS) This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/medical-stocks-lagging-addus-homecare-144005644.html", "providerPublishTime": 1738075205, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UPInF06X6fJkTqeimnpZuQ--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 900, "height": 745, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tlKVbaKmxwUbiS87UIMwQA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ADUS", "ARQT"]}, {"uuid": "1732179d-3857-3a71-a569-3fb82ab45237", "title": "Arcutis to Present at the Guggenheim SMID Cap Biotech Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/arcutis-present-guggenheim-smid-cap-130000121.html", "providerPublishTime": 1737982800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/uwx_iwS2STSt0FCMlgYU2g--~B/aD0yNTU7dz0xNDE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2d8c0be355a8a70c57b55e3391e6adcd", "width": 1417, "height": 255, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dxFlARf0qWHQpI3ygAD2nQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2d8c0be355a8a70c57b55e3391e6adcd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARQT"]}, {"uuid": "c7db3857-9031-390a-92af-47de7f199d38", "title": "IDXX Gears Up for Q4 Earnings: What to Expect From the Stock?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/idxx-gears-q4-earnings-expect-140700282.html", "providerPublishTime": 1737986820, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_aMgtCHWD_AcEvdCSVRbpA--~B/aD00NDU7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62a1df11c94046acffed2654620317fb", "width": 620, "height": 445, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFfQIuDEO9advS2K1dktJw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/62a1df11c94046acffed2654620317fb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IDXX"]}, {"uuid": "ba9d80b5-e561-3165-9816-3020f8eaa2b4", "title": "Robust Analytical Instruments Segment Likely to Aid TMO's Q4 Earnings", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/robust-analytical-instruments-segment-likely-123200505.html", "providerPublishTime": 1737635520, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pZigOrWXuFW6w05A7tUNJQ--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3d0934d8dc803c5d5de0c97254e74ee3", "width": 620, "height": 393, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/X7F2lbbFb6cZsHXVNFMD2w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3d0934d8dc803c5d5de0c97254e74ee3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["TMO"]}, {"uuid": "4652b12b-71da-3b22-bab3-6e3480ceeeaa", "title": "Wall Street Analysts Believe Arcutis Biotherapeutics (ARQT) Could Rally 37.43%: Here's is How to Trade", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/wall-street-analysts-believe-arcutis-145514098.html", "providerPublishTime": 1737039314, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2", "width": 900, "height": 741, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fK_ZnUjpgS53xdJHns_S2A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARQT"]}, {"uuid": "aeb08c70-2699-36c6-acaf-e4945b8b6fde", "title": "Arcutis Biotherapeutics Expects Fiscal Q4 Revenue to Soar Driven by Zoryve Demand", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/arcutis-biotherapeutics-expects-fiscal-q4-090705535.html", "providerPublishTime": 1736759225, "type": "STORY", "relatedTickers": ["ARQT"]}, {"uuid": "6fd226a5-c212-39ff-a08b-ee5df5a8878e", "title": "Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/arcutis-announces-preliminary-unaudited-fourth-133000962.html", "providerPublishTime": 1736688600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/uwx_iwS2STSt0FCMlgYU2g--~B/aD0yNTU7dz0xNDE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2d8c0be355a8a70c57b55e3391e6adcd", "width": 1417, "height": 255, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dxFlARf0qWHQpI3ygAD2nQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2d8c0be355a8a70c57b55e3391e6adcd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARQT"]}, {"uuid": "4ec54646-1214-3ac8-9b27-e83f7ba48832", "title": "High Growth Tech Stocks In The United States To Watch", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-united-180454612.html", "providerPublishTime": 1736445894, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/g2_mg575ViI8K4GruDHCHQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/egaFXHrW49PDzxOt6.F0Wg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/67ac92a32c5f9073ba3559a3e119b22a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARQT", "EVH", "EXLS"]}, {"uuid": "85fabe59-eff8-3c97-ac58-21a0d632c803", "title": "Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/arcutis-biotherapeutics-reports-inducement-grants-210000989.html", "providerPublishTime": 1736197200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/uwx_iwS2STSt0FCMlgYU2g--~B/aD0yNTU7dz0xNDE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2d8c0be355a8a70c57b55e3391e6adcd", "width": 1417, "height": 255, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dxFlARf0qWHQpI3ygAD2nQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2d8c0be355a8a70c57b55e3391e6adcd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARQT"]}]